MRX-2843
MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3 (IC50s of 1.3 nM and 0.64 nM, respectively) .
Product Specifications
CAS Number
1429882-07-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
488.67
Molecular Formula
C29H40N6O
Notes
Research use only, not for human use.
Receptor
FLT3| MERTK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
303581 100 µg
RUNX1 (Acute Myeloid Leukemia 1, Acute Myeloid Leukemia 1 Protein, Alpha Subunit, Alpha Subunit Core Binding Factor, AML 1, AML1, AML1 EVI 1, AML1 EVI 1 Fusion Protein, Aml1 Oncogene, AMLCR 1, AMLCR1, CBF alpha 2, CBF-alpha-2, CBFA 2, CBFA2, Core Binding Factor alpha 2 Subunit, Core Binding Factor Runt Domain alpha Subunit 2, Core-binding Factor Subunit alpha-2, EVI 1, EVI1, Oncogene AML 1, Oncogene AML-1, PEA2 alpha B, PEA2-alpha B, PEBP2 alpha B, PEBP2-alpha B, PEBP2A2, PEBP2aB, Polyomavirus Enhancer Binding Protein 2 alpha B Subunit, Polyomavirus Enhancer-binding Protein 2 alpha B Subunit, Run1, Runt Related Transcription Factor 1, Runt-related Transcription Factor 1, RUNX 1, Runx1, RUNX1_HUMAN, SL3 3 Enhancer Factor 1 alpha B Subunit, SL3-3 Enhancer Factor 1 alpha B Subunit, SL3/AKV Core Binding Factor alpha B Subunit, SL3/AKV Core-binding Factor alpha B Subunit)
Ask
View Details 
